Browse 1,572 kidney cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
Many kidney cancers are now found by chance, on a scan done for another reason, often while they are still small and curable with surgery. About 9 in 10 are renal cell carcinoma. For advanced kidney cancer, combinations of immunotherapy and targeted drugs have transformed outcomes over the past decade. Trials are testing what comes next when these combinations stop working, and whether extra treatment after surgery can keep the cancer from returning.
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
for
Pheochromocytoma, Paraganglioma, Inherited Cancer Syndrome,
Location: San Antonio TX
Sponsor: The University of Texas Health Science Center at San Antonio
Sex: All
Age: 0+
Code: NCT03160274
Recruiting
Active & Responsive
Stereotactic MR-Adaptive Radiation Therapy for Early-stage Renal Cancer
for
Primary Renal Cancer
Location: New York NY
Sponsor: NYU Langone Health
Sex: All
Age: 18+
Code: NCT07767500
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors, Genital Neoplasm, Female,
Location: Boston MA, Bethesda MD, Toronto, Celebration FL,
Sponsor: Marengo Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05592626
Phase 1, Phase 2, Recruiting
Active & ResponsiveNew
This is a Phase 1/1b Study to Evaluate the Safety and Preliminary Antitumor Activity of LTZ-232 in Participants With Advanced/Metastatic Colorectal Cancer and Other Solid Tumors
Sponsor: Masonic Cancer Center, University of Minnesota
Sex: All
Age: 18+
Code: NCT07541573
Phase 1, Recruiting
Active & Responsive
Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients With Advanced or Metastatic Solid Tumors
for
Advanced Malignant Solid Neoplasm,
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: All
Age: 18+
Code: NCT06320405
Phase 1, Phase 2, Recruiting
Active & Responsive
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
for
Solid Tumor, Adult, Colorectal Cancer,
Location: New York NY, Jacksonville FL, Tampa FL, Columbus OH,
Sponsor: A2 Biotherapeutics Inc.
Sex: All
Age: 18+
Code: NCT04981119
Recruiting
Active & Responsive
Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases
for
Clear Cell Renal Cell Cancer (ccRCC),
Location: San Francisco CA
Sponsor: Kelly Fitzgerald, MD
Sex: All
Age: 18+
Code: NCT07043608
Phase 2, Recruiting
Active & Responsive
Met Non Small Cell Cancer Registry (MOMENT)
for
Cancer
Location: Quebec, Ottawa, Fort Lauderdale FL, Toronto,
Sponsor: EMD Serono Research & Development Institute, Inc.
Sex: All
Age: 0+
Code: NCT05376891
Recruiting
Active & Responsive
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
for
Intestinal Neoplasms, Gastrointestinal Neoplasms,
Location: Topsham ME, Westbrook ME, Boston MA, Newton MA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07222800
Phase 3, Recruiting
Active & Responsive
Transformative Research in Diabetic Nephropathy 2.0
for
Diabetic Nephropathies, Kidney Diseases,
Location: Philadelphia PA
Sponsor: University of Pennsylvania
Sex: All
Age: 18+
Code: NCT07444203
Recruiting
Active & Responsive
A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors
for
Solid Tumor
Location: New York NY, Philadelphia PA, Washington D.C. DC,
Sponsor: Biohaven Therapeutics Ltd.
Sex: All
Age: 18+
Code: NCT06384807
Phase 1, Phase 2, Recruiting
Active & Responsive
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
for
Cancer, PDAC - Pancreatic Ductal Adenocarcinoma,
Location: Boston MA, New York NY, Fairfax VA, Durham NC,
Sponsor: Alterome Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06835569
Phase 1, Recruiting
Active & Responsive
Rutgers University Study of the Genetics of Kidney Disease
for
Kidney Disease, Kidney Disease, Chronic,
Location: Piscataway NJ
Sponsor: Rutgers, The State University of New Jersey
Sex: All
Age: 18+
Code: NCT07217535
Recruiting
Active & Responsive
F.L.O.S.S. Project (Facilitated Lessons on Oral and Systemic Health in Survivors)